ondansetron has been researched along with Cystitis in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zirak, MR | 1 |
| Karimi, G | 1 |
| Rahimian, R | 1 |
| Jafarian, AH | 1 |
| Hayes, AW | 1 |
| Mehri, S | 1 |
1 other study available for ondansetron and Cystitis
| Article | Year |
|---|---|
Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Cyclophosphamide; Cystit | 2020 |